Citation: M. Mazumdar et Jr. Glassman, Categorizing a prognostic variable: Review of methods, code for easy implementation and applications to decision-making about cancer treatments, STAT MED, 19(1), 2000, pp. 113-132
Authors:
Moskowitz, CH
Bertino, JR
Glassman, JR
Hedrick, EE
Hunte, S
Coady-Lyons, N
Agus, DB
Goy, A
Jurcic, J
Noy, A
O'Brien, J
Portlock, CS
Straus, DS
Childs, B
Frank, R
Yahalom, J
Filippa, D
Louie, D
Nimer, SD
Zelenetz, AD
Citation: Ch. Moskowitz et al., Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3776-3785
Authors:
Liberman, L
Zakowski, MF
Avery, S
Hudis, C
Morris, EA
Abramson, AF
LaTrenta, LR
Glassman, JR
Dershaw, DD
Citation: L. Liberman et al., Complete percutaneous excision of infiltrating carcinoma at stereotactic breast biopsy: How can tumor size be assessed?, AM J ROENTG, 173(5), 1999, pp. 1315-1322
Authors:
Moskowitz, CH
Nimer, SD
Glassman, JR
Portlock, CS
Yahalom, J
Straus, DJ
O'Brien, JP
Elkin, N
Bertino, JR
Zelenetz, AD
Citation: Ch. Moskowitz et al., The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma, BONE MAR TR, 23(6), 1999, pp. 561-567